Photo: Tara Haelle
It’s not difficult to understand why clinical trials are so incredibly expensive. There’s the recruitment of the participants and their compensation, the cost of the drugs themselves, the work that has to go into ensuring both participants and clinicians are appropriately blinded (at least in double-blinded trials), the many visits to monitor symptoms and improvement, the time spent crunching the data – the dollars add up fast.
It’s harder (at least for me) to grasp where all the money goes for basic science. It’s often just cells in a petri dish, along with the fancy (and very expensive) microscope and computer equipment needed to examine them. Continue reading
